Change in Scope of PAR-08-182: Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Notice Number: NOT-DK-09-011

Key Dates
Release Date:  April 6, 2009

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), (http://www2.niddk.nih.gov)

The purpose of this Notice is to inform the research community that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will NOT accept grants that have as their focus diabetic cardiomyopathy in PAR-08-182 Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases. This language was added when the National Heart Lung and Blood Institute initially joined this FOA. The NHLBI subsequently withdrew from the FOA October 17, 2008 (see NOT-HL-09-110) and studies in diabetic cardiomyopathy will no longer be funded under this FOA.

For more information about NIDDK programs, funding opportunity announcements, and Recovery Act activities, please see our website at http://www2.niddk.nih.gov.

Inquiries

Inquiries concerning this Notice may be directed to:

Ronald Margolis, Ph.D.
Senior Advisor, Molecular Endocrinology
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Two Democracy Plaza, Room 693
6707 Democracy Boulevard
Bethesda, MD 20892-5456
Phone: 301-594-8819
Fax: 301-435-6047
Email: rm76f@nih.gov